CNSP
Cns Pharmaceuticals Inc

7,946
Mkt Cap
$3.85M
Volume
997,027.00
52W High
$114.00
52W Low
$4.93
PE Ratio
-0.11
CNSP Fundamentals
Price
$7.35
Prev Close
$6.20
Open
$6.79
50D MA
$6.51
Beta
0.98
Avg. Volume
19,901.95
EPS (Annual)
-$466.44
P/B
0.36
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved
The company intends to commence the phase 2 study of its lead program, TPI 287, to treat Glioblastoma Multiforme (GBM) by year-end.
Stocktwits·8mo ago
<
...
1
>

Latest CNSP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.